Mayne Pharma Group Limited (MYX.AX)

AUD 6.98

(-0.29%)

Gross Profit Summary of Mayne Pharma Group Limited

  • Mayne Pharma Group Limited's latest annual gross profit in 2024 was 218.52 Million AUD , up 714.24% from previous year.
  • Mayne Pharma Group Limited's latest quarterly gross profit in 2024 FY was 159.11 Million AUD , up 492.87% from previous quarter.
  • Mayne Pharma Group Limited reported a annual gross profit of 26.83 Million AUD in annual gross profit 2023, up 13.03% from previous year.
  • Mayne Pharma Group Limited reported a annual gross profit of 23.74 Million AUD in annual gross profit 2022, down -81.31% from previous year.
  • Mayne Pharma Group Limited reported a quarterly gross profit of 74.32 Million AUD for 2024 Q2, down 0.0% from previous quarter.
  • Mayne Pharma Group Limited reported a quarterly gross profit of 159.11 Million AUD for 2024 FY, up 492.87% from previous quarter.

Annual Gross Profit Chart of Mayne Pharma Group Limited (2024 - 2007)

Historical Annual Gross Profit of Mayne Pharma Group Limited (2024 - 2007)

Year Gross Profit Gross Profit Growth
2024 218.52 Million AUD 714.24%
2023 26.83 Million AUD 13.03%
2022 23.74 Million AUD -81.31%
2021 127.01 Million AUD -9.88%
2020 140.93 Million AUD -32.58%
2019 209.04 Million AUD 13.51%
2018 184.17 Million AUD -25.92%
2017 248.6 Million AUD 63.52%
2016 152.03 Million AUD 92.71%
2015 78.89 Million AUD 6.64%
2014 73.97 Million AUD 95.6%
2013 37.82 Million AUD 74.0%
2012 21.73 Million AUD -0.78%
2011 21.9 Million AUD 22.27%
2010 17.91 Million AUD 1622.98%
2009 1.03 Million AUD 26.69%
2008 820.81 Thousand AUD 485.83%
2007 140.11 Thousand AUD 0.0%

Peer Gross Profit Comparison of Mayne Pharma Group Limited

Name Gross Profit Gross Profit Difference
Firebrick Pharma Limited -22.78 Thousand AUD 959309.025%